CAJ | 학술논문

目的：探讨采用曲美他嗪结合稳心颗粒治疗不稳定心绞痛的临床效果。方法将我院收治的不稳定心绞痛患者中随机抽取94例作为研究对象，将其分为对照组和治疗组，每组各47例。其中对照组单纯采用曲美他嗪治疗，治疗组则在对照组治疗的基础上使用稳心颗粒治疗，对比两组患者的临床疗效、不良反应。结果经对比，治疗组的总有效率为93.620%（44/47），高于对照组的85.11%（40/47），差异具有统计学意义（P<0.05）。结论采用曲美他嗪结合稳心颗粒治疗不稳定心绞痛可提高治疗效果，改善临床症状，安全性较高。
목적：탐토채용곡미타진결합은심과립치료불은정심교통적림상효과。방법장아원수치적불은정심교통환자중수궤추취94례작위연구대상，장기분위대조조화치료조，매조각47례。기중대조조단순채용곡미타진치료，치료조칙재대조조치료적기출상사용은심과립치료，대비량조환자적림상료효、불량반응。결과경대비，치료조적총유효솔위93.620%（44/47），고우대조조적85.11%（40/47），차이구유통계학의의（P<0.05）。결론채용곡미타진결합은심과립치료불은정심교통가제고치료효과，개선림상증상，안전성교고。
Objective To investigate the use of trimetazidine clinical effect wenxinkeli treatment of unstable angina.MethodsNinety-four cases of unstable angina were randomly selected patients in our hospital as the research object,were divided into a control group and the treatment group,47 cases in each group. Among the control group only using trimetazidine treatment group using wenxinkeli treatment control group,based on the clinical efficacy compared two groups of patients with adverse reactions.Results In contrast,the total effective rate of treatment group 93.620%(44/47),significantly higher than the 85.11%(40/47),the difference was statistically significant(P< 0.05). Conclusion Trimetazidine combined wenxinkeli treatment of unstable angina can significantly improve the therapeutic effect,improving clinical symptoms,high security.